ClinicalTrials.govpublic full text
Protective VEGF Inhibition for Isotoxic Dose Escalation in Glioblastoma
glioblastoma, dose escalation, bevacizumab, vegf inhibition, fet pet, vmat, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 912598
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.